Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

906291

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter from the hon. Member for Glasgow North West dated 25 April 2018 on myalgic encephalomyelitis.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	145353
	answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>The Parliamentary Under Secretary of State (Lord O’Shaughnessy) responded to the hon. Member on 21 May.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/05/2018 14:14:05 answering member 4067 label Biography information for Steve Brine
	tabling member	4443 label Biography information for Carol Monaghan

907168

	registered interest
	date	18/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter from the hon. Member for Glasgow North West dated 27 April 2018 on Serco Group PLC’s contract with Public Health England.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	145588
	answer	answer is ministerial correction date of answer 23/05/2018 answer text <p>I have responded to the hon. Member’s letter today.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/05/2018 15:05:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4443 label Biography information for Carol Monaghan

906348

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into Myalgic Encephalomyelitis 2014-2015.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	145354
	answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145355 145356 145357 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

906350

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into Myalgic Encephalomyelitis 2015-2016.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	145355
	answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145354 145356 145357 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

906352

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into Myalgic Encephalomyelitis 2016-2017.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	145356
	answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145354 145355 145357 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

906353

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse he plans to allocate to biomedical research into Myalgic Encephalomyelitis in the current financial year.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	145357
	answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In the period in question, the major National Institute for Health Research (NIHR) funding for biomedical research was through its Biomedical Research Centres and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. The level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each financial year can be found in the table below. The funding for this research came from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be undertaken throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year can be found in the table below. The funding for this research came from a combination of the NIHR, the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure, £</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcomes funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. On this basis, it is not possible to say how much funding is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 145354 145355 145356 question first answered 22/05/2018 12:30:42 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

909054

	registered interest
	date	21/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into myalgic encephalomyelitis in 2013-2014.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	146296
	answer	answer is ministerial correction date of answer 24/05/2018 answer text <p>In the period in question, the major National Institute for Health Research funding for biomedical research was through its Biomedical Research Centres (BRCs) and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. Prior to the financial year 2104-15, the way data was collected does not allow us to directly report the level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Three BRCs were supporting biomedical research into CFS/ME during this time period.</p><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be delivered throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year supported by the CRN can be found in the following table. The funding for this research came from a combination of the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Research funding £</p></td><td><p>CRN expenditure £</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>43,467</p></td><td><p>5,217</p></td></tr><tr><td><p>2012-13</p></td><td><p>114,349</p></td><td><p>13,616</p></td></tr><tr><td><p>2013-14</p></td><td><p>171,860</p></td><td><p>21,353</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. The MRC does not classify research in the area by type and is therefore not able to include a further breakdown by type of project. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>0</p></td></tr><tr><td><p>2012-13</p></td><td><p>504,194</p></td></tr><tr><td><p>2013-14</p></td><td><p>601,509</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcome funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 146297 146298 146299 question first answered 24/05/2018 11:00:59 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

909055

	registered interest
	date	21/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into myalgic encephalomyelitis in 2012-2013.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	146297
	answer	answer is ministerial correction date of answer 24/05/2018 answer text <p>In the period in question, the major National Institute for Health Research funding for biomedical research was through its Biomedical Research Centres (BRCs) and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. Prior to the financial year 2104-15, the way data was collected does not allow us to directly report the level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Three BRCs were supporting biomedical research into CFS/ME during this time period.</p><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be delivered throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year supported by the CRN can be found in the following table. The funding for this research came from a combination of the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Research funding £</p></td><td><p>CRN expenditure £</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>43,467</p></td><td><p>5,217</p></td></tr><tr><td><p>2012-13</p></td><td><p>114,349</p></td><td><p>13,616</p></td></tr><tr><td><p>2013-14</p></td><td><p>171,860</p></td><td><p>21,353</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. The MRC does not classify research in the area by type and is therefore not able to include a further breakdown by type of project. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>0</p></td></tr><tr><td><p>2012-13</p></td><td><p>504,194</p></td></tr><tr><td><p>2013-14</p></td><td><p>601,509</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcome funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 146296 146298 146299 question first answered 24/05/2018 11:00:59 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

909056

	registered interest
	date	21/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into myalgic encephalomyelitis in 2011-2012.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	146298
	answer	answer is ministerial correction date of answer 24/05/2018 answer text <p>In the period in question, the major National Institute for Health Research funding for biomedical research was through its Biomedical Research Centres (BRCs) and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. Prior to the financial year 2104-15, the way data was collected does not allow us to directly report the level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Three BRCs were supporting biomedical research into CFS/ME during this time period.</p><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be delivered throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year supported by the CRN can be found in the following table. The funding for this research came from a combination of the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Research funding £</p></td><td><p>CRN expenditure £</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>43,467</p></td><td><p>5,217</p></td></tr><tr><td><p>2012-13</p></td><td><p>114,349</p></td><td><p>13,616</p></td></tr><tr><td><p>2013-14</p></td><td><p>171,860</p></td><td><p>21,353</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. The MRC does not classify research in the area by type and is therefore not able to include a further breakdown by type of project. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>0</p></td></tr><tr><td><p>2012-13</p></td><td><p>504,194</p></td></tr><tr><td><p>2013-14</p></td><td><p>601,509</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcome funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 146296 146297 146299 question first answered 24/05/2018 11:00:59 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan

909057

	registered interest
	date	21/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding from the public purse was allocated to biomedical research into myalgic encephalomyelitis in 2010-2011.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	146299
	answer	answer is ministerial correction date of answer 24/05/2018 answer text <p>In the period in question, the major National Institute for Health Research funding for biomedical research was through its Biomedical Research Centres (BRCs) and Units. These support research funded by the NIHR itself and also research funded by other public, charity and industry research funders. Prior to the financial year 2104-15, the way data was collected does not allow us to directly report the level of funding for biomedical research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Three BRCs were supporting biomedical research into CFS/ME during this time period.</p><p> </p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows high-quality clinical research funded by charities, research funders and life-sciences industry to be delivered throughout the National Health Service. The level of funding for biomedical research into CFS/ME for each financial year supported by the CRN can be found in the following table. The funding for this research came from a combination of the Medical Research Council (MRC) and medical research charities. Expenditure from the CRN itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Research funding £</p></td><td><p>CRN expenditure £</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>43,467</p></td><td><p>5,217</p></td></tr><tr><td><p>2012-13</p></td><td><p>114,349</p></td><td><p>13,616</p></td></tr><tr><td><p>2013-14</p></td><td><p>171,860</p></td><td><p>21,353</p></td></tr></tbody></table><p> </p><p>The MRC spend on research directly relating to CFS/ME can be found in the following table. The MRC does not classify research in the area by type and is therefore not able to include a further breakdown by type of project. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2010-11</p></td><td><p>0</p></td></tr><tr><td><p>2011-12</p></td><td><p>0</p></td></tr><tr><td><p>2012-13</p></td><td><p>504,194</p></td></tr><tr><td><p>2013-14</p></td><td><p>601,509</p></td></tr></tbody></table><p> </p><p>The NIHR and the MRC welcome funding applications for research into any aspect of human health, including biomedical research into CFS/ME. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The NIHR recognises that CFS/ME is a debilitating condition and is speaking with the United Kingdom CFS/ME Research Collaborative and patient representatives about how best we can support a joined up approach to high quality research into this complex disorder.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 146296 146297 146298 question first answered 24/05/2018 11:00:59 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4443 label Biography information for Carol Monaghan